These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28138749)

  • 1. The relationship between postmenopausal women's sclerostin levels and their bone density, age, body mass index, hormonal status, and smoking and consumption of coffee and dairy products.
    Kalem MN; Kalem Z; Akgun N; Bakırarar B
    Arch Gynecol Obstet; 2017 Mar; 295(3):785-793. PubMed ID: 28138749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between postmenopausal women's sclerostin levels and their bone density, age, body mass index, hormonal status, and smoking and consumption of coffee and dairy products.
    Namlı Kalem M
    Arch Gynecol Obstet; 2017 Jul; 296(1):135. PubMed ID: 28510095
    [No Abstract]   [Full Text] [Related]  

  • 3. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
    Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
    J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum sclerostin levels associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis.
    Xu XJ; Shen L; Yang YP; Lu FR; Zhu R; Shuai B; Li CG; Wu MX
    Chin Med J (Engl); 2013 Jul; 126(13):2480-4. PubMed ID: 23823821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Habitual tea drinking and bone mineral density in postmenopausal Turkish women: investigation of prevalence of postmenopausal osteoporosis in Turkey (IPPOT Study).
    Hamdi Kara I; Aydin S; Gemalmaz A; Aktürk Z; Yaman H; Bozdemir N; Kurdak H; Sitmapinar K; Devran Sencar I; Başak O; Akdeniz M; Işildar H; Burgut E; Ozcan S; Akça U; Dağdeviren N; Ungan M
    Int J Vitam Nutr Res; 2007 Nov; 77(6):389-97. PubMed ID: 18622949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting serum sclerostin in postmenopausal women.
    Kawada T
    Arch Gynecol Obstet; 2017 Jul; 296(1):133. PubMed ID: 28501932
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum sclerostin levels were positively correlated with fat mass and bone mineral density in central south Chinese postmenopausal women.
    Sheng Z; Tong D; Ou Y; Zhang H; Zhang Z; Li S; Zhou J; Zhang J; Liao E
    Clin Endocrinol (Oxf); 2012 Jun; 76(6):797-801. PubMed ID: 22151063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women.
    Mirza FS; Padhi ID; Raisz LG; Lorenzo JA
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1991-7. PubMed ID: 20156921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating sclerostin and estradiol levels are associated with inadequate response to bisphosphonates in postmenopausal women with osteoporosis.
    Morales-Santana S; Díez-Pérez A; Olmos JM; Nogués X; Sosa M; Díaz-Curiel M; Pérez-Castrillón JL; Pérez-Cano R; Torrijos A; Jodar E; Rio LD; Caeiro-Rey JR; Reyes-García R; García-Fontana B; González-Macías J; Muñoz-Torres M
    Maturitas; 2015 Dec; 82(4):402-10. PubMed ID: 26358930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study.
    Ardawi MS; Rouzi AA; Al-Sibiani SA; Al-Senani NS; Qari MH; Mousa SA
    J Bone Miner Res; 2012 Dec; 27(12):2592-602. PubMed ID: 22836717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women.
    Drake MT; Srinivasan B; Mödder UI; Peterson JM; McCready LK; Riggs BL; Dwyer D; Stolina M; Kostenuik P; Khosla S
    J Clin Endocrinol Metab; 2010 Nov; 95(11):5056-62. PubMed ID: 20631014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population.
    Han W; Bai X; Wang N; Han L; Sun X; Chen X
    Arch Osteoporos; 2017 Dec; 12(1):50. PubMed ID: 28527105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density.
    Voskaridou E; Christoulas D; Plata E; Bratengeier C; Anastasilakis AD; Komninaka V; Kaliontzi D; Gkotzamanidou M; Polyzos SA; Dimopoulou M; Terpos E
    Horm Metab Res; 2012 Nov; 44(12):909-13. PubMed ID: 22581647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of coffee consumption and smoking habit on bone mineral density.
    Demirbag D; Ozdemir F; Ture M
    Rheumatol Int; 2006 Apr; 26(6):530-5. PubMed ID: 16025331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum 25-hydroxyvitamin D and bone turnover markers in Palestinian postmenopausal osteoporosis and normal women.
    Kharroubi A; Saba E; Smoom R; Bader K; Darwish H
    Arch Osteoporos; 2017 Dec; 12(1):13. PubMed ID: 28124221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of sclerostin in the bone loss of postmenopausal chinese women with type 2 diabetes.
    Zhou YJ; Li A; Song YL; Zhou H; Li Y; Tang YS
    Chin Med Sci J; 2013 Sep; 28(3):135-9. PubMed ID: 24074614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of serum sclerostin in healthy pre- and postmenopausal women.
    Ardawi MS; Al-Kadi HA; Rouzi AA; Qari MH
    J Bone Miner Res; 2011 Dec; 26(12):2812-22. PubMed ID: 21812027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum sclerostin levels decline in post-menopausal women with osteoporosis following treatment with intermittent parathyroid hormone.
    Piemonte S; Romagnoli E; Bratengeier C; Woloszczuk W; Tancredi A; Pepe J; Cipriani C; Minisola S
    J Endocrinol Invest; 2012 Oct; 35(9):866-8. PubMed ID: 22842667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparisons of serum sclerostin levels among patients with postmenopausal osteoporosis, primary hyperparathyroidism and osteomalacia.
    Kaji H; Imanishi Y; Sugimoto T; Seino S
    Exp Clin Endocrinol Diabetes; 2011 Jul; 119(7):440-4. PubMed ID: 21667439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating TGF-β1 levels are negatively correlated with sclerostin levels in early postmenopausal women.
    Cheng Q; Tang W; Sheu TJ; Du Y; Gan J; Li H; Hong W; Zhu X; Xue S; Zhang X
    Clin Chim Acta; 2016 Apr; 455():87-92. PubMed ID: 26826396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.